James P. Kelly
2019 - Vanda Pharmaceuticals
In 2019, James P. Kelly earned a total compensation of $2.2M as Former Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $288,622 |
|---|---|
| Option Awards | $805,077 |
| Salary | $493,370 |
| Stock Awards | $618,600 |
| Other | $42,741 |
| Total | $2,248,410 |
Kelly received $805.1K in option awards, accounting for 36% of the total pay in 2019.
Kelly also received $288.6K in non-equity incentive plan, $493.4K in salary, $618.6K in stock awards and $42.7K in other compensation.
Rankings
In 2019, James P. Kelly's compensation ranked 5,332nd out of 13,971 executives tracked by ExecPay. In other words, Kelly earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,332 out of 13,971 | 62nd |
Division Manufacturing | 1,984 out of 5,695 | 65th |
Major group Chemicals And Allied Products | 701 out of 2,194 | 68th |
Industry group Drugs | 590 out of 1,880 | 69th |
Industry Pharmaceutical Preparations | 438 out of 1,392 | 69th |
Source: SEC filing on April 22, 2020.
Kelly's colleagues
We found four more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2019.
2019
Mihael Polymeropoulos
Vanda Pharmaceuticals
Chief Executive Officer
2019
Gian Reverberi
Vanda Pharmaceuticals
Former Senior Vice President, Chief Commercial Officer
2019
Timothy Williams
Vanda Pharmaceuticals
General Counsel
2019
Gunther Birznieks
Vanda Pharmaceuticals